Spero Therapeutics, Inc.SPRONASDAQ
Loading
Cash generated from core business operations
Latest
$-27.67M
↑ 31% vs avg
Percentile
P70
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-39.98M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-27.67M | -18.0% |
| 2024 | $-23.44M | +28.9% |
| 2023 | $-32.99M | -326.8% |
| 2022 | $-7.73M | +88.0% |
| 2021 | $-64.35M | +25.1% |
| 2020 | $-85.87M | -71.7% |
| 2019 | $-50.02M | -26.2% |
| 2018 | $-39.63M | -1.3% |
| 2017 | $-39.11M | -35.1% |
| 2016 | $-28.96M | - |